The most recent poll on the Invasive Cardiovascular Angiography and Interventions Clinical Topic Collection asked potential respondents what, if any, impact they have observed as a result of the ORBITA (Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina) trial, which was presented 1 year ago.

The results overwhelmingly show that the respondents saw little impact in percutaneous coronary intervention volume. Nearly 90% noted no impact of ORBITA on procedure decisions. Two percent actually suggested an increase, and 8% observed a decrease.

The ORBITA trial has generated many heated debates, particularly on social media, but the results of this poll suggest that the trial's results have had little clinical impact.

Thanks to those who took the time to respond.

Keywords: Angioplasty, Angina, Stable, Coronary Artery Disease

< Back to Listings